FRNM — Freenome, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2017526 ·
Last close
$15.99
Market Cap
—
52W High
$17.50
52W Low
$9.95
ADV30
974,240
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
4
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 30,409,000 | -223,469,000 | -219,343,000 | 507,053,000 | 1,770,189,000 | -1,263,136,000 | -110,669,000 |
| Dec 2024 | 2,882,000 | -291,973,000 | -274,421,000 | 551,920,000 | 1,606,937,000 | -1,055,017,000 | -196,367,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | $94.31B | $435.61 | — |
| NTRA | Natera, Inc. | $59.47B | $412.56 | — |
| DGX | QUEST DIAGNOSTICS INC | $26.08B | $236.32 | — |
| LH | LABCORP HOLDINGS INC. | $25.11B | $309.64 | — |
| GH | Guardant Health, Inc. | $23.79B | $177.25 | — |
News headlines (Yahoo Finance, 1h cache)
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
2026-08-12 13:00 · Yahoo
Freenome (FRNM) Climbed, But What Is Driving Attention Now?
2026-08-11 03:19 · Yahoo
Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook
2026-07-31 20:22 · Yahoo
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
2026-07-27 12:00 · Yahoo
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
2026-07-20 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.